338 related articles for article (PubMed ID: 25380948)
1. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M
Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
[TBL] [Abstract][Full Text] [Related]
6. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
[TBL] [Abstract][Full Text] [Related]
7. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
[TBL] [Abstract][Full Text] [Related]
8. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
9. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen.
Stewart ZA; Shetty R; Nair R; Reed AI; Brophy PD
Transplant Proc; 2011 Dec; 43(10):3994-6. PubMed ID: 22172885
[TBL] [Abstract][Full Text] [Related]
10. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.
Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M
Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
Kumar J; Shatat IF; Skversky AL; Woroniecki RP; Del Rio M; Perelstein EM; Johnson VL; Mahesh S
Pediatr Nephrol; 2013 Feb; 28(2):333-8. PubMed ID: 23052653
[TBL] [Abstract][Full Text] [Related]
14. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
Ino A; Kaori S; Takei T; Nitta K
CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
[TBL] [Abstract][Full Text] [Related]
15. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
Kamar N; Faguer S; Esposito L; Guitard J; Nogier MB; Durand D; Rostaing L
Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient.
Kumar D; Gourishankar S; Mueller T; Cockfield S; Weinkauf J; Vethanayagam D; Humar A
Transpl Infect Dis; 2009 Apr; 11(2):167-70. PubMed ID: 18803617
[TBL] [Abstract][Full Text] [Related]
17. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
18. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.
Okamoto M; Koshino K; Sakai K; Nobori S; Matsuyama M; Ushigome H; Okajima H; Masuzawa N; Yoshimura N
Clin Transplant; 2011 Jul; 25 Suppl 23():53-8. PubMed ID: 21623916
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for post-transplant recurrences of FSGS.
Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
[TBL] [Abstract][Full Text] [Related]
20. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
